France Contraceptive Devices Market

France Contraceptive Devices Market Insights Forecasts to 2035

• The France Contraceptive Devices Market Size Was Estimated at USD 406.5 Million in 2024.
• The France Contraceptive Devices Market Size is Expected to Grow at a CAGR of Around 7.1% from 2024 to 2035.
• The France Contraceptive Devices Market Size is Expected to Reach USD 864.1 Million By 2035.

According to a research report published by Decision Advisor & Consulting, the France Contraceptive Devices Market size is projected to reach USD 864.1 million by 2035, growing at a CAGR of 7.1% from 2025 to 2035. The France Contraceptive Devices market is driven by increased awareness of family planning, government initiatives like free contraception for young women, and the growing popularity of long-acting reversible contraceptives (LARCs). Other key drivers include advancements in contraceptive technology, a strong healthcare infrastructure, and a focus on women's health and reproductive autonomy. 

Market Overview

The France contraceptive devices market refers to the healthcare industry focused on the manufacture, distribution, and utilization of devices designed to prevent pregnancy. It includes a wide range of products such as condoms, intrauterine devices, diaphragms, and other barrier or hormonal devices. The market encompasses manufacturers, distributors, healthcare providers, pharmacies, and online platforms that supply these devices to consumers. Its growth is influenced by factors such as population demographics, awareness of family planning, government policies promoting contraceptive access, technological advancements, and changing consumer preferences. Essentially, it represents the organized framework in France for providing safe, accessible, and effective contraceptive solutions.

The France contraceptive devices market is experiencing steady growth, driven by rising demand for both traditional and long-acting contraceptive methods and government initiatives, such as providing free contraception for women under 25, along with strict regulatory oversight by the National Agency for the Safety of Medicines and Health Products (ANSM), which supports market expansion. Overall, the market is shaped by increasing adoption of modern contraceptive methods, evolving consumer preferences, and strong institutional support, making it a dynamic sector in France’s healthcare industry.

France is recording increasing notifications of syphilis and gonorrhea, which is driving demand for contraceptive devices. According to a 2024 survey, 60% of clinicians felt that they were not adequately trained in STI counseling, creating a knowledge gap that condom brands aim to fill with education initiatives. Cost-conscious users are immediately able to access free condoms as part of the government's January 2023 policy for people under 26. The evidence-based narrative that condoms prevent both infection and pregnancy is used by brands to integrate educational content into packaging and digital apps. The promotion of condom use during World AIDS Day 2024 further normalized its use on university campuses. The French contraceptive device market is now positioned as an essential public health tool due to the combination of policy incentives and public campaigns.

Report Coverage

This research report categorizes the market for the France contraceptive devices market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France contraceptive devices market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France contraceptive devices market.

Driving Factors

The main drivers of the French contraceptive devices market are strong government support and healthcare infrastructure, including initiatives that provide free contraception to women under 25, which increases accessibility and adoption. Rising awareness of sexually transmitted infections (STIs) and the importance of family planning has also fueled demand for contraceptive methods. Technological advancements, such as long-acting reversible contraception (LARCs), non-hormonal options, and user-friendly designs, are encouraging greater uptake. Collectively, these factors are driving consistent growth in France’s contraceptive devices sector.

Restraining Factors

Restraining factors for the France contraceptive devices market include concerns over side effects, cultural barriers, limitations in rural access, and the high cost and lengthy approval times for new hormonal methods. Safety anxieties related to certain hormonal contraceptives, recent regulatory restrictions on older pill generations, and potential insurance reimbursement adjustments also curb market growth, especially for the hormonal sub-segments. 

Market Segmentation

The France contraceptive devices market share is categorized by product type, gender, material, and distribution channel.

• The condoms segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The France contraceptive devices market is segmented by product type into condoms, diaphragms and cervical caps, vaginal sponges, and others. Among these, the condoms segment accounted for the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This segmental growth is because they offer the dual protection of preventing both pregnancy and sexually transmitted infections (STIs), are easily accessible, cost-effective, and have minimal side effects. Additionally, policy-backed free distribution programs in France have further boosted their market share. 

• The female segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.  

The France contraceptive devices market is segmented by gender into male and female. Among these, the female segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The female segmental growth is due to the wide availability and higher adoption of female-focused contraceptive options, including IUDs, implants, and diaphragms, which offer long-acting and highly effective pregnancy prevention. Additionally, strong government support, such as free contraception for women under 25, increased accessibility and usage. Growing awareness of reproductive health, preference for long-acting reversible contraception, and frequent medical consultations among women further contributed to the segment’s leading market share.

• The latex segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.  

The France contraceptive devices market is segmented by material into latex and non-latex. Among these, the latex segment dominated the market in 2024 and is projected to grow at a significant CAGR during the forecast period. The latex segmental growth is due to its widespread availability, cost-effectiveness, and strong consumer familiarity, making latex-based products the most commonly purchased contraceptive option. Latex also offers high elasticity, durability, and reliable protection, which contribute to its continued preference. Additionally, well-established manufacturing processes and broad distribution across pharmacies and retail outlets further strengthened the segment’s leading position.

• The retail pharmacies segment held the largest market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

The France contraceptive devices market is segmented by distribution channel into retail pharmacies, hospitals, specialty clinics, and others. Among these, the retail pharmacies segment held the largest market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The retail pharmacies segmental growth is due to its high accessibility, widespread presence across France, and consumer preference for convenient, confidential purchasing of contraceptive products. Retail pharmacies also offer a broad product range, immediate availability, and professional guidance, making them the primary channel for both over-the-counter and prescription contraceptive devices.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France contraceptive devices market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Reckitt Benckiser
• Bayer AG
• Cooper Surgical Inc.
• Church & Dwight Co.
• LifeStyles Healthcare
• Laboratoire CCD (FR)
• HRA Pharma (FR)
• Mylan Laboratories
• Church & Dwight
• CooperSurgical
• Pfizer
• Pregna International

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In June 2025, Hims & Hers Health announced its acquisition of the European digital health platform Zava to expand its presence in France, Germany, the UK, and Ireland
• In September 2021, the French Health Minister announced that France would offer free hormonal contraception pills, intrauterine devices (IUDs), contraceptive patches, and injections to all women up to age 25, a measure that took effect on January 1, 2022. 

Market Segment

This study forecasts revenue at the France, regional, and country levels from 2020 to 2035. Decision Advisor has segmented the France contraceptive devices market based on the below-mentioned segments:

France Contraceptive Devices Market, By Product Type

• Condoms
• Diaphragms
• Cervical Caps
• Vaginal Sponges
• Others

France Contraceptive Devices Market, By Gender

• Male
• Female

France Contraceptive Devices Market, By Material

• Latex
• Non-Latex

France Contraceptive Devices Market, By Distribution Channel

• Retail Pharmacies
• Hospital
• Specialty Clinics
• Others

Frequently Asked Questions (FAQ)

1. What is the CAGR of the France contraceptive devices market?

The France contraceptive devices market size is expected to grow at a CAGR of around 7.1% from 2024 to 2035.

2. What is the France magnetic contraceptive devices market size in 2024?

The France contraceptive devices market size was estimated at USD 406.5 million in 2024.

3. What is the projected market size of the France contraceptive devices market by 2035?

The France contraceptive devices market size is expected to reach USD 864.1 million by 2035.

4. Which product type held the largest market share in 2024?

The condoms segment held the largest market share in 2024.

5. Which material segment held the largest share in 2024?

The latex segment, due to its affordability and strong reliability.

6. Which distribution channel held the biggest share in 2024?

Retail pharmacies, offering convenient and confidential access.

7. Why did the female segment dominate the market?

Because of wider contraceptive options and free access for young women.